Stem cells share several characteristics of cancer cells including loss of contact inhibition and immortality. Therefore, stem cells represent an excellent model system in which to define the molecular mechanisms underlying cancer development and progression. Several signal transduction pathways including leukemia inhibitory factor, Wnt and FGF have been demonstrated to function in stem cell self-renewal and differentiation. However, more recently bone morphogenetic proteins (BMPs) have emerged as key regulators of stem cell fate commitment. Intriguingly, BMPs have disparate roles in regulating the biology of embryonic stem (ES) cells compared with neural crest stem cells (NCSCs). Furthermore, although BMPs block neural differentiation of ES cells from both mouse and human, they contribute to self-renewal specifically in mouse ES cells. These observations strongly suggest that combinations of extracellular factors regulate stem cells, and that crosstalk between intracellular signaling pathways precisely defines stem cell fate commitment. In this review, we focus on the role of BMP signaling in mouse and human ES cells compared with NCSCs. We then discuss how the molecular effectors of BMP signaling may contribute to cancer, and thus represent potential targets for therapeutic intervention.
Introduction
All stem cells are defined by two key characteristics: the ability to proliferate by the symmetrical division of cellular contents and the ability to form specialized cell types through asymmetrical cell division (Chambers and Smith, 2004) . Stem cells share many of the characteristics of cancer cells including the ability to proliferate by a process of self-renewal and a loss of contact inhibition (Gammill and Bronner-Fraser, 2002 ). Therefore, the mechanisms governing the balance of stem cell renewal versus differentiation represent a useful model for understanding the development of human cancer.
Several signaling pathways have been demonstrated to play a role in stem cell determination. These pathways include those of the leukemia inhibitory factor (LIF) (Matsuda et al., 1999) , Wnt protein (Sato et al., 2004) and bone morphogenetic proteins (BMPs) (Ying et al., 2003) . However, a detailed understanding of the molecular mechanisms underlying regulation of stem cell fate by these extracellular factors remains unknown. BMPs are members of the TGF-b superfamily that have long been established to function in the development and regulation of a wide range of biological systems. These extracellular ligands were originally isolated as components of bone extracts that induced ectopic cartilage and bone formation when implanted in muscle (Wozney et al., 1988) . However, BMPs have since been demonstrated to function in multiple developmental processes including: dorsoventral patterning within the neural tube, the induction of mesoderm during gastrulation and hematopoiesis (Attisano and Wrana, 2002) . As might be expected from these complex in vivo functions, BMPs also play key roles in regulating fate choices during stem cell differentiation. For example, BMPs direct mesenchymal stem cells to chondrogenic and osteogenic cell lineages (Tiedemann et al., 2001) . BMPs have also been shown to regulate fate choices in neural crest stem cells (NCSCs) (Shah et al., 1996) . Moreover, the recent discovery of a key role for BMP in maintaining embryonic stem (ES) cell self-renewal (Ying et al., 2003) is consistent with the notion that this family of secreted factors have broad roles in regulating stem cell biology. In this review, we will focus on reviewing the disparate role of BMP signaling in the biology of mouse and human ES cells, as well as in rodent NCSCs. We then go on to discuss how the disruption of BMP signaling in stem cells may lead to cancer, and how defining the fate decisions of stem cells at the molecular level in response to BMP may identify protein targets for the treatment of cancer.
Stem cells isolated from different sources exhibit unique characteristics
There are three basic types of stem cells that exist in mammals: somatic, germinal and embryonal (Sell, 2004) . Somatic stem cells including mesenchymal and those of the hematopoietic system are considered the most limited in their potential because they produce the cells participating in the renewal of adult tissues (Wobus and Boheler, 2005) . Embryonic germ cells are derived from cultured primordial germ cells, the embryonic precursors of adult gametes (Donovan et al., 2001) . Pluripotent stem cells have also been obtained from spontaneously arising teratoma tumors of mouse testis that contain a disorganized mixture of differentiated cell types derived from all three germ layers (Chambers and Smith, 2004) . These germline tumors can be produced when male genital ridges from E11 to E13 mouse embryos are transplanted into the testes of adult recipients (Chambers and Smith, 2004) . Teratomas can be either benign or malignant, and in the case of the latter contain embryonic carcinoma (EC) stem cells that form tumors when transplanted to secondary locations (Chambers and Smith, 2004) . EC cells exhibit a limited ability to generate chimeric mice when introduced into the inner cell mass (ICM) of host blastocysts, and frequently exhibit chromosomal abnormalities that are likely the result of their transient tumorigenic state (Wobus and Boheler, 2005) .
The stem cells with the widest developmental capacity are ES cells derived from the ICM of blastocyst embryos. ES cells grow indefinitely in culture, maintain a stable karyotype and because they are pluripotent are capable of contributing to all three germ layers: the ectoderm, mesoderm and endoderm (Chambers and Smith, 2004) . This ability of cultured ES cells to colonize all tissues and produce a chimera when injected into a host ICM has been widely exploited for the analysis of in vivo gene function (Chambers and Smith, 2004) . This is dramatically illustrated in the case of tetraploid embryos that are generated by electrofusing two cellstage diploid embryos. This results in the disruption of the ICM that can be completely rescued by aggregation with exogenous ES cells (Tanaka et al., 2001) . As ES cells exhibit the characteristics of stable self-renewal and pluripotency, they are also widely used to model embryonic development in vitro. However, it is important to note that because they are derived from the transient ICM cell population and cultured ex vivo under a variety of conditions, a true ES cell equivalent may not exist in vivo.
Stem cells have also been isolated from explants of mammalian neural crest tissue. The neural crest is a group of cells originating from the dorsal neural tube in vertebrates during the early stages of embryogenesis (Chai et al., 2003) . After delaminating from the neural tube, neural crest cells migrate along discreet pathways to give rise to diverse cell types including neurons and glia of the peripheral nervous system, smooth muscle, bone and melanocytes (Anderson, 2000) (Figure 1 ). Clonal analysis has confirmed that the neural crest is a heterogeneous population composed of self-renewing pluripotent NCSCs, in addition to cells with a restricted spectrum for differentiation (Le Douarin and Dupin, 2003) . NCSCs purified from rat neural tube explants treated with TGF-b family growth factors differentiate into specific cell types including autonomic neurons, glia and smooth muscle that are derived from the neural crest in vivo (Shah et al., 1996) . Like the ICM, the neural crest is a transient cell population that arises during development. However, NCSCs have been isolated from fetal rat sciatic nerve, confirming that these stem cells can persist at postmigratory sites (Morrison et al., 1999) . The potential for NCSCs to exist in adult tissue may therefore have important implications for tumor development in neural crest-derived tissues.
Regulation of ES cells and NCSCs by BMP
The first clue that BMPs might play a role in regulating the maintenance of ES cells came from investigations of cell fate choices in Xenopus. In these studies, it was shown that BMPs inhibit neuronal differentiation, and that by blocking BMP signals, a default neuronal cell fate emerged (Munoz-Sanjuan and Brivanlou, 2002) . Subsequent studies in mouse ES cells demonstrated similar BMP-dependent inhibition of neuronal differentiation (Munoz-Sanjuan and Brivanlou, 2002) . Moreover, BMPs have been shown to maintain cultured mES cells in an undifferentiated state (Ying et al., 2003) . In this study, mES cells treated with LIF in the absence of feeder cells or serum exhibited limited self-renewal and differentiated into cells expressing neuronal markers (Ying et al., 2003) . However, treatment with BMP suppressed neural differentiation, and in combination with LIF was sufficient to maintain self-renewal of mES cells in the absence of serum or feeder cells (Ying et al., 2003) . One of the key observations in these studies was the ability to maintain undifferentiated mES cells in the absence of exogenous factors such as feeder cells, which One critical contribution of BMPs to self-renewal is likely via regulation of the expression of inhibitor of differentiation (Id) genes. This is because overexpression of Ids in the absence of BMP and presence of LIF permits self-renewal of mES cells under serum-free conditions in the absence of feeder cells (Ying et al., 2003) . More recent work has suggested that BMPs further support self-renewal in mouse ES cells by inhibiting mitogen-activated protein kinase (MAPK) pathways (Qi et al., 2004) . Specifically, mES cells cultured with serum in the absence of feeder cells exhibit reduced levels of active extracellular receptor kinase (ERK), and intracellular p38 MAPK shortly after BMP4 treatment (Qi et al., 2004) . Furthermore, specific inhibition of ERK or p38 using pharmacological agents in mES cells dramatically improves self-renewal, and thus mimics the effects of BMP4 treatment (Qi et al., 2004) . These studies point to key synergistic roles for BMP and LIF in maintaining mES cells in an undifferentiated state and hint at broader interactions with other signaling systems.
The majority of ES cell research has focused on mouse cells due to the ethical concerns and tissue scarcity inherent in using cells derived from human embryos. Thus, earlier human work focused on EC cell lines that showed that BMPs induced differentiation to a phenotype that was similar to extraembryonic endoderm (Pera and Herszfeld, 1998) . However, there are now about 70 hES cells lines that have been derived from unwanted extra embryos from couples completing in vitro fertilization (Draper and Fox, 2003) . In these untreated hES cell cultures, spontaneous differentiation similar to that observed in EC cells has been observed , suggesting that BMPs may promote differentiation of hES cells, which contrasts with their clear role in inhibiting mES cell differentiation. Indeed, treatment of hES cells grown on feeder layers in the presence of serum induces differentiation into primitive endoderm lineages correlating with a loss of stem cell marker expression . Surprisingly, the effect of exogenous BMP was dependent on the feeder cells used in the experiments, and when batches of cells that did not support differentiation were analysed, it was found they expressed Gremlin, a secreted antagonist of BMP . Furthermore, treatment with the exogenous BMP antagonist Noggin prevented spontaneous differentiation into primitive endoderm, strongly suggesting that in these hES cells, BMPs induce differentiation . Of note, as is observed in mES cells, the blocking of BMP activity by Noggin treatment leads to differentiation into neural precursors . Thus, one common thread to arise from analysis of Xenopus, mouse and human systems is that BMPs have maintained an evolutionarily conserved role to block neural differentiation during early development.
As in mES cells, BMPs function in the context of other signaling pathways. Of note, analysis of a different hES cells line under different culture conditions (Matrigel-coated plates and fibroblast-conditioned media) showed that in the continuous presence of FGF signaling, BMP induces hES cells to differentiate into the trophoblast lineage (Xu et al., 2002) . This is a striking finding because this extraembryonic cell fate is not generally accessible to mES cells. Moreover, by culturing cells in the absence of conditioned media but in the presence of FGF and Noggin to block BMP signaling, hES cells can be maintained in a pluripotent state (Wang et al., 2005; Xu et al., 2005) . Thus, BMPs clearly induce the differentiation of hES cells, which contrasts their role in mES cells. Of note, recent analysis of Smad activation in hES cells has revealed a key role for the TGF-b Smad2/3 arm of the pathway in maintaining hES cells in an undifferentiated state (Amit et al., 2004) .
Why might hES and mES cells display such divergent responses to BMPs? One possibility is that these ES cell populations reflect different developmental stages. The various phenotypic differences between mES and hES cells are consistent with this, as is the observation that the ES cells from these species exhibit different growth requirements (Munoz-Sanjuan and Brivanlou, 2002) . Indeed, while analysis of the transcriptome of mES versus hES has identified a potential core molecular program that may define a conserved pluripotency in these culture systems, there are many differences that likely include simple species differences, but might also include signatures of fundamental distinctions between different classes of ES cells (Sato et al., 2003) . Moreover, hES cells can be induced to differentiate into trophoblasts, a phenomenon rarely observed in mES cells (Xu et al., 2002) . Therefore, hES and mES cells may reflect different types of stem cells at different stages of embryonic development .
The role of BMP in regulating stem cell populations is further complicated when evaluating stem cells derived from the neural crest. In both human and mouse ES cells, BMPs function to inhibit neural differentiation. However, BMP2 treatment of mouse NCSCs in vitro results in the rapid expression of mammalian AchaeteScute complex homologue (Mash1), an early marker of neurogenesis (Shah et al., 1996) , and these BMP-treated NCSCs ultimately differentiate into autonomic neurons (Shah et al., 1996) . Wnt signaling has long been implicated in neural crest induction (Schmidt and Patel, 2005) , as well as in the differentiation of melanocytes from cultured NCSCs isolated from mouse neural tube (Shah et al., 1996) . In vivo and in cell culture, NCSCs lacking the Wnt signaling component b-catenin fail to generate sensory neurons (Hari et al., 2002) . Complementary to this, embryos expressing a constitutively active form of b-catenin specifically in NCSCs develop sensory neurons at the expense of virtually all other neural crest derivatives . Recently, BMPs have been shown to antagonize this Wnt response, but when added simultaneously with Wnt1 suppress all neural differentiation and maintain NCSC multipotency (Kleber et al., 2005) . These data indicate that in NCSCs combined BMP and Wnt signals regulate self-renewal, whereas the individual factors alone promote specific lineage differentiation.
Research on human NCSCs has been particularly limited because trunk neural crest induction and migration occur at E21-E24 in humans, a time point before pregnancy is typically detected and therapeutic abortions are preformed (Pomp et al., 2005) . Therefore, it is not yet known if BMP directs neural differentiation or self-renewal of human NCSCs. By defining the conserved pathways implicated in stem cell self-renewal including BMP in both mouse and human cell populations, it ultimately may be possible to define the molecular mechanisms of stem cell fate determination.
BMPs regulate stem cell fate in conjunction with other signaling pathways
The current theory of stem cell differentiation argues cell fate decisions are determined by the actions of signaling networks in response to combinations of extracellular ligands. This dynamic model of fate specification emphasizes crosstalk between different signaling pathways via different transcription factors ultimately resulting in the expression of patterns of target genes that specify distinct cell fates. Collectively, these data suggest a dynamic role for BMP in specifying cell fate. How can the same protein exhibit a paradoxical role in neural differentiation or self-renewal in different populations of stem cells? The answer may lie in the stem cells themselves, that is, in what context that BMP signals are received. One possibility is that differently responding cell populations express specific combinations of BMP effectors during development that influence how the cell responds to BMP. A second key mechanism is that the switch of BMP from a differentiation to a self-renewal signal is dependent on the activity of other signaling pathways. Thus, understanding what the context of BMP signaling means in molecular signaling terms is critical in understanding how ES cells are regulated at a biological systems level.
BMPs are part of the larger superfamily of TGF-b ligands, which signal through a defined molecular pathway (Attisano and Wrana, 2002) . Extracellular BMPs bind with weak affinity to type I and type II ligand-specific receptors alone, but with high affinity to typeI/typeII heteromeric complexes (Figure 2 ). Upon BMP-induced heteromeric complex formation, the constitutively active serine/threonine kinase of the type II receptor phosphorylates type I receptor in its GS domain. The intracellular messengers downstream from (Hollnagel et al., 1999) in cultured mES cells resulting in stem cell self-renewal (Ying et al., 2003) . Ids function as negative regulators of the basic helix-loop-helix (bHLH) transcription factors (Miyazawa et al., 2002) . Members of the bHLH family heterodimerize with ubiquitously expressed and/or tissue specific bHLH E proteins to form a complex that activates transcription from gene promoters containing an E box (Miyazawa et al., 2002) . As Id proteins lack the basic domain, heterodimerization of Id proteins with nuclear bHLH factors negatively regulates the protein and downregulates target gene expression. One key bHLH family member is the neurogenic Mash1 gene that is expressed in undifferentiated mouse and human ES cells (Ying et al., 2003) . Therefore, BMP-induced expression Id proteins may function to block the default progression of neural differentiation in ES cells triggered by the primed expression of Mash1.
Smads in the BMP pathway further regulate gene expression by a second pathway that involves cooperation with tissue-specific DNA-binding proteins that bind target DNA sequences with a high degree of specificity (Massague and Wotton, 2000) . For BMP-regulated Smads, few of these DNA-binding proteins have been identified. Those that have been characterized include OAZ that directly binds Smads on the xVent2 promoter and that may promote differentiation of the olfactory epithelium (Hata et al., 2000) . GATA factors have also been shown to cooperate with BMP-regulated Smads in an intronic enhancer of the Smad7 gene, although this does not appear to require direct physical interactions (Benchabane and Wrana, 2003) . BMP-regulated gene expression is controlled independent of cell type through direct Smad binding, and in a cell-type-specific manner via interaction with tissue-specific transcription factors.
These Smad-dependent transcriptional targets coupled to crosstalk between the BMP and other signaling pathways likely mediate transcriptional programs associated with cell fate choices.
Signaling crosstalk in the control of stem cell fate Typically, mES cells are propagated in the presence of serum and in coculture with a layer of fibroblasts that provide the LIF that inhibits ES cell differentiation (Lo et al., 2003) . LIF is a member of the IL6 cytokine family that signal through receptor complexes including the transmembrane receptor, gp130. LIF directly binds its receptor (LIFR) containing a long cytoplasmic tail with homology to gp130. The LIF-LIFR complex then recruits gp130 into a trimeric complex, which in ES cells activates several families of intracellular secondary messengers including three members of the Janus family kinases, Jak1, Jak2 and Jak3 (Ernst et al., 1996) . Activated Jaks subsequently phosphorylate the signal transducer and activator of transcription protein STAT3. STAT proteins are SH2 domain-containing dimers that upon tyrosine phosphorylation translocate to the nucleus to bind DNA and direct specific transcriptional initiation. LIF treatment acts synergistically with BMP to maintain mES cells in a pluripotent state. This synergism may occur via independent regulation of STAT and Smad target genes, but may also involve coassembly of STAT3 and Smad1 with the transcriptional coactivators CREB-binding protein (CBP)/p300. This complex, which is induced upon LIF and BMP stimulation of neural progenitors, can act at the STAT binding element of LIF-BMP synergistic target genes such as the astrocyte marker gene glial fibrillary acidic protein, GFAP (Nakashima et al., 1999) . Consistent with this possibility, STAT3 activation is required but is not sufficient to maintain the undifferentiated state of mES cells cotreated with BMPs and cultured in the absence of serum (Anderson et al., 1997) . Whether this cooperativity does indeed require the physical assembly of STAT3-CBP/p300-Smad1 into a single complex to maintain mES cells is not yet known (Figure 3) .
Several transcription factors including the POU transcription factor Oct4 have been shown to be essential to maintain pluripotency in the ICM, but until recently none of them had been shown to function independently of the LIF pathway. In 2003, two groups identified a divergent homeobox protein, Nanog, which was named after the mythological Celtic land of the ever-young 'Tir nan Og'. Nanog directs pluripotency in mouse ICM and mES cells and functions independently from LIF-STAT3 activation. Mitsui et al., 2003) . Nanog is detected in the ICM and early germ cells, as well as in the ES and EC cell lines derived from these stages . Nanog overexpression relieves mES cells cultured without feeder cells in the presence of serum from dependence on LIF stimulation for self-renewal . Furthermore, Nanog-deficient mES cells loose pluripotency and differentiate into extraembryonic endoderm lineages (Mitsui et al., 2003) . Interestingly, overexpression of Nanog in mES cells cultured in the absence of serum or BMP sustains a substantial level of Id protein expression (Ying et al., 2003) . In hES cells, high levels of Nanog transcript are present in cells cultured in the absence of feeder cells with conditioned media, or after treatment with a Wnt-specific pharmacological activator that maintains pluripotency (Sato et al., 2004) . These data confirm that intracellular factors play a key role in defining stem cell fate, but how these factors interact with extracellular cues such as BMPs and their signaling pathways is largely unexplored.
Although LIF signaling is sufficient to support selfrenewal in the presence of serum or BMP of mES cells, it does not prevent the differentiation of hES cell lines (Sato et al., 2004) . However, Wnt signaling is detected in undifferentiated mouse ES cells and is subsequently downregulated upon differentiation (Sato et al., 2004) . Extracellular Wnt proteins activate the canonical Wnt signaling pathway by binding the Frizzled seventransmembrane span receptor and stabilizing intracellular b-catenin (Schmidt and Patel, 2005 ). Intact b-catenin then translocates to the nucleus where it interacts with T-cell factor/lymphocyte enhancer factor (Tcf/Lef) transcription factors to regulate expression of target genes. Activation of the Wnt canonical pathway using a pharmacological inhibitor of glycogen synthase kinase-3 has been demonstrated to be sufficient to maintain self-renewal of mouse and human ES cells (Sato et al., 2004) . In this study, Wnt treatment of mES cells cultured in serum on feeders, or hES cells cultured in the absence of serum and feeders maintained an undifferentiated morphology and expression of the pluripotent-state-specific transcription factors Oct4 and Nanog (Sato et al., 2004) . Thus, Wnts are another signaling pathway controlling ES cell maintenance. As TGF-b's have been implicated in hES cell maintenance, and the Wnt and TGF-b pathways can directly interact (Labbe et al., 2000) , these data might suggest that cooperation occurs by direct physical interactions. These results are consistent with earlier studies that showed that Wnt signaling was blocked in F9 EC cells subsequent to retinoic acid-induced differentiation to visceral endoderm (Shibamoto et al., 2004) . The secreted signaling molecules BMP2 and BMP4 promote neuronal specification in premigratory cells of the neural crest (Shah et al., 1996) . After separation from the neuroepithelium, neural crest cells enter a migration staging area where they are subjected to changing environmental signals that impact their migration and expression of fate-determining molecules including ligand receptors (Anderson et al., 1997) .
Neural crest cells are a heterogeneous, multipotent population that differentiate into neurons and glia of the peripheral nervous system, melanocytes, smooth muscle and cartilage (Le Douarin and Dupin, 2003) . Clonal analysis of neural crest precursors has confirmed that a subset of these cells generate progeny that produce multiple fates upon differentiation, and that some of these progenitors are stem cells because they generate self-renewing multipotent progeny (Shah et al., 1996) . Furthermore, stem cells can be isolated from cultures of sciatic peripheral nerve (Morrison et al., 1999) , thus confirming that neural crest-derived stem cells persist in postmigratory tissue and could potentially play a role in subsequent tumorigenesis. BMPs directly induce differentiation of NCSCs derived from rat neural tube explants into cells expressing Mash1, a marker expressed in autonomic precursor cells (Shah et al., 1996) . However, continuous BMP signaling is required to commit neural crest cells to a neuronal fate, which suggests these molecules direct a multistep process of specification and determination. Knockout models have not provided insight into the requirement for BMP2/4 in autonomic neurogenesis because mutant mouse embryos are lethal before analysis is possible (Anderson, 2000) . In contrast to BMPs, TGF-b's induce NCSCs to assume a smooth muscle fate (Shah et al., 1996) , whereas neuregulin treatment promotes gliogenesis (Joseph et al., 2004) . Wnts on the other hand direct NCSCs towards sensory neuronal fate . Surprisingly, unlike their individual activities, treating NCSCs with Wnt and BMP together maintains the cells in a pluripotent state (Kleber et al., 2005) . Since Wnt pathway components interact physically with Smads (Labbe et al., 2000) , this distinct response to concomitant activation may reflect unique cellular activities of this crosstalk. Consistent with this, Smad4, b-catenin and LEF were recently shown to interact functionally to control expression of the BMP target gene Msx2 (Hussein et al., 2003) .
BMP signaling may control the biology of stem cell cancers
Hints that BMPs might regulate development of stem cell cancers arose from the discovery that Juvenile Hamartomatous Polyposis Syndrome in which patients are at risk for developing gastrointestinal cancers arises from mutations in the BMP type I receptor, BMPRIA (Howe et al., 2001) . Interestingly, conditional inactivation of BMPRIA in the mouse causes tumors resembling the human syndrome (He et al., 2004) . Of note, this is accompanied by expansion of the intestinal epithelial stem cell pool (He et al., 2004) . This expansion is proposed to occur because BMPs suppress Wnt signaling, thus regulating stem cell self-renewal. This example provides a compelling case that disturbances in BMP signaling may underlie other stem cell-derived cancers.
Neural crest cells and metastatic cancer cells share phenotypic similarities such as high motility and invasiveness, and can follow the same migratory pathways (Gammill and Bronner-Fraser, 2002) . Interestingly, transcriptome analysis has revealed both metastatic melanomas and migratory neural crest cells express comparable groups of genes including extracellular matrix molecules and proteins regulating the actin cytoskeleton (Gammill and Bronner-Fraser, 2002) . A popular hypothesis is that cancers can arise from the transformation of stem cells of the neural crest including neuroblastomas, neurofibromas and peripheral neuroectodermal tumors (Sell, 2004) . Although there is no published evidence that NCSCs persist postnatally, it is possible that even a small number of persistent stem cells may represent the target for transformation events leading to these childhood cancers.
Manipulation of BMP effectors may play a role in cancer therapy
Collectively, these findings strengthen the idea that BMPs regulate the choice of cell fates in mammals at the earliest stages of stem cell function. It is by this regulation that BMPs control self-renewal of stem cells, the loss of regulation of which has direct consequences for tumorigenesis. By manipulating self-renewal decisions by targeting signaling pathways through drug treatment or possibly RNA interference, it may become possible to influence the source of recurring tumors. Furthermore, by defining the signals that drive stem cells' fate choices, it may become convenient to differentiate highly uniform populations of specific cell types from single stem cells. These cells may then be used to test tissue specificity of drugs, or potentially be employed in regenerative medicine. One restriction to the study of hNCSCs has been the limited supply of available tissue. However, a recent publication describes the generation of cells expressing the neural crestspecific molecular markers Snail, dHand, Msx1 and Sox9, by coculturing hES cells with the mouse PA6 stromal line exhibiting stromal-derived inducting activity (SIDA) (Pomp et al., 2005) . In this study, subsequent treatment of SIDA-treated hES cells with high concentrations of BMP4 induced autonomic neuron lineages expressing tyrosine hydroxylase and peripherin, whereas treatment with low concentrations of BMP4 promoted the generation of sensory neurons expressing Brn3a and peripherin (Pomp et al., 2005) . In future, these methods may be used to generate a valuable source of hNCSCs that may be used to evaluate the molecular role of BMP in stem cell fate decisions.
Conclusions
In summary, it is clear that extrinsic components of stem cell identity including BMP and LIF are not unique to stem cells, while some intrinsic factors such as Nanog remain stem cell specific. While ES cells are pluripotent and exhibit a capacity for extended self-renewal, NCSCs are multipotent and have a limited capacity for selfrenewal. It is intriguing to consider the possibility that BMPs exhibit alternative cell fates in these two stem cell pools due to the existence of different intrinsic factors such as Nanog. Future studies characterizing the intracellular components regulated by BMP treatment of ES cells and NCSCs may yield the identity of alternative regulators controlling the distinct effectors of BMP in self-renewal versus differentiation fate decisions. These factors may represent novel targets for the earlier detection and therapeutic treatment of cancer.
